The oncology market landscape has witnessed significant transformation in recent years, with specialized segments like mucinous cystic neoplasms (MCNs) gaining prominence due to advancing diagnostic capabilities and therapeutic innovations. These rare but clinically significant tumors represent a growing area of commercial interest, driven by unmet medical needs and evolving...